`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`STEADYMEDLTD.,
`
`Petitioner,
`
`v.
`
`UNITED THERAPEUTICS CORPORATION
`
`Patent Owner.
`
`Case [PR2016-00006
`
`Patent No. 8,497,393 B2
`
`DECLARATION OF JAMES DOWDLE UNDER 37 C.F.R.§ 42.63(B)
`
`I, James Dowdle declare:
`
`1,
`
`2.
`
`Tam fluent in the Japanese and English languages.
`
`] am a Japanese translator from Japanese to English, and have been
`
`working as a translator since 2012.
`
`WEST.269322494.|
`
`IPR2016-00006
`SteadyMed- Exhibit 1019 - Page 1
`
`Liquidia's Exhibit No. 1050
`IPR2020-00770 - Page 001
`
`Liquidia's Exhibit No. 1050
`IPR2020-00770 - Page 001
`
`
`
`3.
`
`I received my Bachelor's Degree in Japanese from Brigham Young
`
`University in 2012. To receive my degree, | was required to do an entire thesis
`
`presentation in Japanese.
`
`| have also lived in Japan, where| worked as an intern
`
`teaching English and studying Japaneseliterature and culture.
`
`4,
`
`I personally translated a Japanese Patent Application, which
`
`translation is now Ex. 1007, and mytranslation is a true and accurate translation of
`
`the Japanese Patent Application No, 56-122328A (Kawakami), Crystalline Amine
`
`Salt of Methanoprostacyclin Derivative, Manufacturing Method Thereof, and
`
`Purifying Method Thereof.
`
`5.
`
`lamconfident that this translation is true and accurate, because it was
`
`checked by Mr. Boris Levine, whois an experienced Japanese-to-English
`
`translator.
`
`I hereby declare that all statements made herein are of my own personal
`
`knowledge;all statements made on information and belief are believed to be true;
`
`and all statements were made with the knowledgethat willful false statements and
`
`the like so madeare punishable by fine or imprisonment, or both, under Section
`
`
`
`James Dowdl
`Technical Language Services,Inc.
`April
`Le)
`, 2016
`
`WESPH269322494 |
`
`to
`
`IPR2016-00006
`
`SteadyMed - Exhibit 1019 - Page 2
`
`Liquidia's Exhibit No. 1050
`IPR2020-00770 - Page 002
`
`Liquidia's Exhibit No. 1050
`IPR2020-00770 - Page 002
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the attached DECLARATION OF
`
`JAMES DOWDLE UNDER37 C.F.R. § 42.63(B), was served via electronic mail
`
`to the following:
`
`Stephen B. Maebius
`George Quillin
`FOLEY & LARDNER LLP
`UT393-IPR@foley.com
`
`Shaun R. Snader
`UNITED THERAPEUTICS CORP.
`ssnader@unither.com
`
`Douglas Carsten
`Richard Torcezon
`Robert Delafield
`WILSON, SONSINI, GOODRICH & ROSATI
`dcarsten@wsegr.com
`rtorezon@wsgr.com
`bdelafield(@wsegr.com
`
`Date: April 29, 2016
`
`Respectfully submitted,
`
`/s Stuart E. Pollack /
`Stuart E. Pollack, J.D., Ph.D.
`Reg. No. 43,862
`DLA Piper LLP (US
`
`/s Lisa A. Haile /
`Lisa A. Haile, J.D., Ph.D.
`Reg. No. 38,347
`DLA Piper LLP (US
`p
`
`WEST\269322494.1
`
`IPR2016-00006
`
`SteadyMed - Exhibit 1019 - Page 3
`
`Liquidia's Exhibit No. 1050
`IPR2020-00770 - Page 003
`
`Liquidia's Exhibit No. 1050
`IPR2020-00770 - Page 003
`
`